Global Protein Market Analysis 2017-2018 & Forecast to 2023 with Subfocus on Oncoproteomics

By , in Artificial Intelligence on . Tagged width:

DUBLIN, Sept. 27, 2018 /PRNewswire/ —

The “Protein Analysis: Subfocus on Oncoproteomics” report has been added to’s offering.

Rising demand and U.S. Food and Drug Administration (FDA) approvals of personalized medicines due to their numerous benefits have been two of the major factors driving the market growth. As protein analysis is widely used for personalized medicines, it enables the market to grow significantly. Additionally, a rising aging population and an increase in lifestyle diseases have been motivating the market. According to theWorld Health Organization, cardiovascular diseases (CVDs) have been estimated as one of the major causes of mortality, and they account for more than 17.3 million deaths per year. It is further estimated that the fatalities due to CVDs are expected to reach 23.6 million by 2030.

These lifestyle diseases are growing at a significant rate, and protein analysis can be act as a bridge for drug discovery, customized medicines, biomarkers and research programs. Further, the diabetic population was recorded as 415 million in 2015, and it is projected that this will reach 642 million by 2040. This prevalence of lifestyle-related disorders reflects the need for protein analysis as a bridge for the drug discovery, customized medicines, and biomarkers, thus promoting the market. Healthcare research and development (R&D) spending plays a significant role in the growth of the protein analysis market. As transformative research is responsible for the development of new biomarkers and next-generation diagnostics and therapeutics, healthcare expenditure is a crucial element for the market.

Globally, national governments have been revising their healthcare expenditure taking into account increasing R&D. As a result, the overall increase in the healthcare expenditure globally would drive the market, as research institutes will be able to obtain increased funding by governments for drug discovery. Strict regulatory approvals of protein analysis instruments have been one of the major restraints of the protein analysis market. These products require regulatory approval by the FDA and other regulatory bodies as they govern a broad range of activities such as quality management, design and development, labeling, manufacturing and so forth. Additionally, there are various regulations for manufacturers and their customers, along with regulations in the areas of health and safety, packaging, product content and trade restrictions.

Manufacturers are required to follow complex foreign and U.S. laws and regulations, such as the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act, and other local laws, violations of which can result in penalties and restrictions on the conduct of business. Additionally, the high costs of these instruments affect their adoption in the industry. Both of these factors have a negative effect on the growth of protein analysis market. However, technological advancements in mass spectrometry/liquid chromatography (MS/LC) instrumentation, protein separation and emerging markets in developing economies such as China, Japan, and South Korea are expected to drive the market growth in the upcoming years.

Key Topics Covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

  • Driving Forces
  • Ongoing Research in Personalized Medicine
  • Aging Population and Increase in Lifestyle-Related Diseases
  • Rising Healthcare and R&D Expenditures
  • Restraints
  • Tough Regulatory Approvals
  • High Cost of Protein Analysis Instruments and Equipment
  • Opportunities
  • Technological Advancements
  • Emerging Markets
  • Protein Analysis
  • Technology Platforms
  • Biochip-based Protein Analysis Technologies
  • Onco-Protein Analysis

Chapter 4 Market Breakdown by End Use

  • Drug Discovery and R&D
  • Clinical Diagnosis
  • Others

Chapter 5 Market Breakdown by Instrumentation/Reagent Technology

  • Mass Spectrometry
  • Mass Spectrometry Imaging
  • Biochips
  • Protein Microarrays
  • Chromatography
  • Microscale Thermophoresis
  • NMR Spectroscopy
  • Electrophoresis
  • Capillary Electrophoresis
  • Others
  • X-Ray Crystallography Instrumentation
  • Protein Fractionation

Chapter 6 Market Breakdown by Type of Disease/Diagnostic

  • Cancer
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Kidney Cancer
  • Lung Cancer
  • Lymphoma Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Thyroid Cancer
  • Infectious Diseases
  • Diabetes
  • Neurological Disorders
  • Alzheimer’s Disease
  • Schizophrenia
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • HLA Typing
  • Prenatal Testing

Chapter 7 Market Breakdown by Type of Service and Industry Application

  • Quantitative Services
  • Laboratory Services
  • Simple Protein Identification
  • Multidimensional LC-MS
  • Protein Mass Spectrometry
  • 2D Difference Gel Electrophoresis
  • Protein Profiling
  • Protein-Identification and Separation Services
  • Protein Sequencing Services
  • Protein-Imaging Services
  • Breakdown by Application Industry
  • Biotechnology Industry
  • Pharmaceutical Industry
  • Other (Research Institutes and Academics)
  • Market Breakdown by Service
  • Market Breakdown by Industry
  • Biotechnology Industry Applications by Region
  • Pharmaceutical Industry Applications by Region
  • Other Industry Applications by Region

Chapter 8 Market Breakdown by Region

Chapter 9 Patent Review/New Developments

  • Competitive Landscape
  • Top Companies
  • Key Strategies

Chapter 10 Company Profiles

  • Abcodia
  • Advance Proteome Therapeutics Corp.
  • Agilent Technologies Inc.
  • Anatrace
  • Applied Microarrays Inc.
  • Arrayit Corp.
  • Astute Medical Inc.
  • Avacta
  • Ayoxxa Biosystems Gmbh
  • Biodesix Inc.
  • Biognosys Ag
  • Biomerieux
  • Bioproximity
  • Bio-Rad Laboratories Inc.
  • Bio-Techne Inc.
  • Brucker
  • Cambridge Protein Arrays Ltd.
  • Caprion Biosciences Inc.
  • Cdi Laboratories Inc.
  • Creative Proteomics Inc.
  • Crelux Gmbh
  • Crystalgenomics
  • Danaher Corp.
  • Epicypher
  • Evotec
  • Fluidigm
  • Ge Healthcare
  • Glaxosmithkline Plc
  • Gd Biosciences
  • Gl Sciences
  • Healthtell
  • Hybrigenics Sa
  • Immunovia
  • Imtakt Corp.
  • Integrated Diagnostics Inc.
  • Indi Molecular
  • Labcyte Inc.
  • Luminex Corp.
  • Merck Kgaa
  • Mosaiques Diagnostics And Therapeutics Ag
  • MRM Proteomics
  • MS Bioworks Llc
  • Mycartis
  • Myriad Genetics Inc.
  • Nantomics
  • Newomics
  • Nirmidas Biotech
  • Opko Health Inc.
  • Perkinelmer
  • Pfizer
  • Phylogica
  • Pressure Biosciences Inc.
  • Prometic Life Science Inc.
  • Protagen Ag
  • Protea Biosciences Inc.
  • Proteocyte Ai
  • Proteogenix
  • Proteome Sciences
  • Proteomics International
  • Proteovista
  • Qiagen Nv
  • Quansys Biosciences
  • Quanterix
  • Quest Diagnostics
  • Raybiotec
  • Repligen Corp.
  • Retrogenix
  • Samdi Tech Inc.
  • Sera Prognostics
  • Shimadzu Corp.
  • Showa Danko Kk
  • Sigma-Aldrich Corp.
  • Siscapa Assay Technologies
  • Somalogic Inc.
  • Sphere Fluidics
  • Spoton Clinical Diagnostics
  • SQI Diagnostics
  • Thermofisher Scientific Inc.
  • Thorne Diagnostics
  • Vermillion
  • Waters Corp.
  • Xencor

For more information about this report visit

Media Contact:

Research and Markets
Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:–forecast-to-2023-with-subfocus-on-oncoproteomics-300720292.html

SOURCE Research and Markets